Literature DB >> 26456868

Canine hyperlipidaemia.

P G Xenoulis1, J M Steiner1,2.   

Abstract

Hyperlipidaemia refers to an increased concentration of lipids in the blood. Hyperlipidaemia is common in dogs and has recently emerged as an important clinical condition that requires a systematic diagnostic approach and appropriate treatment. Hyperlipidaemia can be either primary or secondary to other diseases. Secondary hyperlipidaemia is the most common form in dogs, and it can be a result of endocrine disorders, pancreatitis, cholestasis, protein-losing nephropathy, obesity, as well as other conditions and the use of certain drugs. Primary hyperlipidaemia is less common in the general canine population but it can be very common within certain breeds. Hypertriglyceridaemia of Miniature Schnauzers is the most common form of primary hyperlipidaemia in dogs but other breeds are also affected. Possible complications of hyperlipidaemia in dogs include pancreatitis, liver disease, atherosclerosis, ocular disease and seizures. Management of primary hyperlipidaemia in dogs is achieved by administration of ultra low-fat diets with or without the administration of lipid lowering drugs such as omega-3 fatty acids, fibrates, niacin and statins.
© 2015 British Small Animal Veterinary Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26456868     DOI: 10.1111/jsap.12396

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  17 in total

Review 1.  Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research.

Authors:  Lu Wang; Ting Xu; Ruifeng Wang; Xiaobing Wang; Dong Wu
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.199

2.  Acute phase protein response and changes in lipoprotein particle size in dogs with systemic inflammatory response syndrome.

Authors:  Erica Behling-Kelly; Carol E Haak; Patrick Carney; Jessica Waffle; Kelly Eaton; Robert Goggs
Journal:  J Vet Intern Med       Date:  2022-04-14       Impact factor: 3.175

3.  The long-term safety of D-allulose administration in healthy dogs.

Authors:  Naohito Nishii; Satoshi Takashima; Yui Kobatake; Masaaki Tokuda; Hitoshi Kitagawa
Journal:  J Vet Med Sci       Date:  2017-09-17       Impact factor: 1.267

4.  Therapy of Canine Hyperlipidemia with Bezafibrate.

Authors:  V De Marco; K S M Noronha; T C Casado; E R Nakandakare; J C Florio; E Z Santos; C Gilor
Journal:  J Vet Intern Med       Date:  2017-04-06       Impact factor: 3.333

5.  Clinofibrate improved canine lipid metabolism in some but not all breeds.

Authors:  Yohtaro Sato; Nobuaki Arai; Hidemi Yasuda; Yasushi Mizoguchi
Journal:  J Vet Med Sci       Date:  2018-03-26       Impact factor: 1.267

6.  Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.

Authors:  Katja Kalenyak; Romy M Heilmann; Chris H A van de Lest; Jos F Brouwers; Iwan A Burgener
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

7.  Lipid and metabolic profiles in female dogs with mammary carcinoma receiving dietary fish oil supplementation.

Authors:  Keidylania Costa-Santos; Karine Damasceno; Ricardo Dias Portela; Ferlando Lima Santos; Genira Carneiro Araújo; Emanoel Ferreira Martins-Filho; Laís Pereira Silva; Thiago Doria Barral; Stefanie Alvarenga Santos; Alessandra Estrela-Lima
Journal:  BMC Vet Res       Date:  2019-11-08       Impact factor: 2.741

8.  Evaluation of visceral fat mass in dogs by computed tomography.

Authors:  Itsuma Nagao; Koichi Ohno; Takuro Nagahara; Nozomu Yokoyama; Taisuke Nakagawa; Reina Fujiwara; Kie Yamamoto; Yuko Goto-Koshino; Hirotaka Tomiyasu; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2019-09-25       Impact factor: 1.267

9.  Serum triglyceride and cholesterol concentrations and lipoprotein profiles in dogs with naturally occurring pancreatitis and healthy control dogs.

Authors:  Panagiotis G Xenoulis; Paul J Cammarata; Rosemary L Walzem; Jan S Suchodolski; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2020-02-03       Impact factor: 3.333

10.  Starch sources influence lipidaemia of diabetic dogs.

Authors:  Fabio Alves Teixeira; Daniela Pedrosa Machado; Juliana Toloi Jeremias; Mariana Ramos Queiroz; Cristiana Ferreira Fonseca Pontieri; Marcio Antonio Brunetto
Journal:  BMC Vet Res       Date:  2020-01-03       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.